Changes to the instructions for medical use of medicinal products

Professional development Vacancies
Changes to the instructions for medical use of medicinal products
Zyprexa® Zydis (olanzapine)

By Order of the Ministry of Health of Ukraine No. 649 of 26.07.13, the instructions for medical use (hereinafter – the instructions) of the original (reference) medicinal product were approved,…

Read more
Casodex (bicalutamide)

MoH of Ukraine Order No. 684 of 02.08.13 approved the instruction for medical use (hereinafter – the instruction) of the original (reference) medicinal product,…

Read more
Plaquenil (hydroxychloroquine)

MoH order No. 684 of 02.08.13 approved the instruction for medical use (hereinafter, the instruction) of an original (reference) medicinal product that…

Read more
Plavix (clopidogrel)

By Order of the Ministry of Health of Ukraine No. 615 of 18.07.13, the instructions for medical use of the original (reference) medicinal product containing in its…

Read more
Controloc (pantoprazole)

MoH order No. 615 of 18.07.13 approved the instruction for medical use (hereinafter, the instruction) of an original (reference) medicinal product that…

Read more
Crestor (rosuvastatin)

By order of the Ministry of Health of Ukraine No. 615 of 18.07.13, the instruction for medical use (hereinafter – the instruction) of the original (reference) medicinal product containing… was approved

Read more
Fluditec (carbocisteine)

MoH order No. 593 of 12.07.13 approved the instruction for medical use (hereinafter, the instruction) of an original (reference) medicinal product that…

Read more
Ciprobay (ciprofloxacin)

MoH order No. 593 of 12.07.13 approved the instruction for medical use (hereinafter, the instruction) of an original (reference) medicinal product that…

Read more
Augmentin (amoxicillin and clavulanic acid)

MoH order No. 574 of 05.07.13 approved the instructions for medical use (hereinafter – the instructions) of the original (reference) medicinal…

Read more
Arifon® Retard (indapamide)

MoH order No. 574 of 05.07.13 approved the instruction for medical use (hereinafter, the instruction) of an original (reference) medicinal product that…

Read more